{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:25:15Z","timestamp":1792808715096,"version":"4.5.0"},"reference-count":187,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.humimm.2026.111703","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T02:11:46Z","timestamp":1771899106000},"page":"111703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments"],"prefix":"10.1016","volume":"87","author":[{"given":"Qamar","family":"Abuhassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0430-5019","authenticated-orcid":false,"given":"Ali M","family":"Atoom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya Bhanu","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bavanilatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashna","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisher","family":"Khazratov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.111703_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.humimm.2026.111703_b0010","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.puhe.2024.10.033","article-title":"Global cancer statistics of young adults and its changes in the past decade: Incidence and mortality from GLOBOCAN 2022","volume":"237","author":"Li","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.humimm.2026.111703_b0015","article-title":"The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4253\/wjge.v8.i20.733","article-title":"Colorectal cancer screening: opportunities to improve uptake, outcomes, and disparities","volume":"8","author":"Shahidi","year":"2016","journal-title":"World Journal of Gastrointestinal Endoscopy"},{"key":"10.1016\/j.humimm.2026.111703_b0025","unstructured":"J.G. Rodrigues, Glyco-Immune Checkpoint in Cancer: Role of Glycosylation in Tumour Immune Response Modulation, (2023)."},{"key":"10.1016\/j.humimm.2026.111703_b0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41575-023-00847-3","article-title":"Reduction in colorectal cancer incidence by screening endoscopy","volume":"21","author":"Brenner","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.humimm.2026.111703_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-025-03702-4","article-title":"Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1","volume":"25","author":"Abolhasani","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.humimm.2026.111703_b0040","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.34172\/ijdrc.2023.e2","article-title":"Pan cyclin-dependent kinase inhibitors for the treatment of breast cancer","volume":"1","author":"Izadi","year":"2023","journal-title":"International Journal of Drug Research in Clinics"},{"key":"10.1016\/j.humimm.2026.111703_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153247","article-title":"EP4 receptor as a novel promising therapeutic target in colon cancer","volume":"216","author":"Karpisheh","year":"2020","journal-title":"Pathology-Research and Practice"},{"key":"10.1016\/j.humimm.2026.111703_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106338","article-title":"Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer","volume":"144","author":"Karpisheh","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.humimm.2026.111703_b0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/156800911795538066","article-title":"Cytokines, inflammation and colon cancer","volume":"11","author":"Klampfer","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.humimm.2026.111703_b0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12935-022-02528-8","article-title":"The role of Th17 cells in the pathogenesis and treatment of breast cancer","volume":"22","author":"Karpisheh","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.humimm.2026.111703_b0065","article-title":"The dual role of TGF\u03b2 in human cancer: from tumor suppression to cancer metastasis","volume":"2012","author":"Lebrun","year":"2012","journal-title":"International Scholarly Research Notices"},{"key":"10.1016\/j.humimm.2026.111703_b0070","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1158\/0008-5472.CAN-08-0206","article-title":"Transforming growth factor \u03b2 subverts the immune system into directly promoting tumor growth through interleukin-17","volume":"68","author":"Nam","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2026.111703_b0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2026.111703_b0080","doi-asserted-by":"crossref","unstructured":"Z. Chen, A. Laurence, J.J. O'Shea, Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation, in, Elsevier, pp. 400-408.","DOI":"10.1016\/j.smim.2007.10.015"},{"key":"10.1016\/j.humimm.2026.111703_b0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri2742","article-title":"TH17 cells in tumour immunity and immunotherapy","volume":"10","author":"Zou","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0090","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/314620","article-title":"Th17 cell plasticity and functions in cancer immunity","volume":"2015","author":"Gu\u00e9ry","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.humimm.2026.111703_b0095","doi-asserted-by":"crossref","first-page":"66382","DOI":"10.18632\/oncotarget.18807","article-title":"Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2026.111703_b0100","first-page":"362","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma, Blood, the Journal of the American Society of","volume":"112","author":"Muranski","year":"2008","journal-title":"Hematology"},{"key":"10.1016\/j.humimm.2026.111703_b0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12013-011-9276-3","article-title":"Expression of Th17 cells in breast cancer tissue and its association with clinical parameters","volume":"62","author":"Yang","year":"2012","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.humimm.2026.111703_b0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jff.2014.12.043","article-title":"An insight into the role of citrus bioactives in modulation of colon cancer","volume":"13","author":"Kaur","year":"2015","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.humimm.2026.111703_b0115","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1039\/C6TX00079G","article-title":"In vitro DNA adduct profiling to mechanistically link red meat consumption to colon cancer promotion","volume":"5","author":"Hemeryck","year":"2016","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.humimm.2026.111703_b0120","first-page":"106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA-ATLANTA-"},{"key":"10.1016\/j.humimm.2026.111703_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11671-016-1520-8","article-title":"New updates pertaining to drug delivery of local anesthetics in particular bupivacaine using lipid nanoparticles","volume":"11","author":"Beiranvand","year":"2016","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.humimm.2026.111703_b0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1535-6108(02)00053-3","article-title":"Focus on colon cancer","volume":"1","author":"Markowitz","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humimm.2026.111703_b0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.humimm.2026.111703_b0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.33.3.357","article-title":"Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival","volume":"33","author":"J\u00e4rvinen","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.humimm.2026.111703_b0145","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0016-5107(99)70524-9","article-title":"Impact of family history on screening and surveillance","volume":"49","author":"Burt","year":"1999","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.humimm.2026.111703_b0150","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0016-5085(90)90323-S","article-title":"Colorectal adenomas in the Lynch syndromes: results of a colonoscopy screening program","volume":"98","author":"Lanspa","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humimm.2026.111703_b0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/359235a0","article-title":"APC mutations occur early during colorectal tumorigenesis","volume":"359","author":"Powell","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2026.111703_b0160","first-page":"2657","article-title":"Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway","author":"Cai","year":"2015","journal-title":"OncoTargets and Therapy"},{"key":"10.1016\/j.humimm.2026.111703_b0165","series-title":"World Cancer Report, in","author":"Stewart","year":"2003"},{"key":"10.1016\/j.humimm.2026.111703_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70123","article-title":"TRPC1 and TRPC5 in Colorectal Cancer: Mechanisms, Prognostic Markers, and Therapeutic Targets","volume":"86","author":"Abbas","year":"2025","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.humimm.2026.111703_b0175","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gr.152942.112","article-title":"CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer","volume":"23","author":"Ling","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.humimm.2026.111703_b0180","doi-asserted-by":"crossref","first-page":"e1583","DOI":"10.1038\/cddis.2014.541","article-title":"Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p","volume":"6","author":"Ma","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.humimm.2026.111703_b0185","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1200\/JCO.2000.18.9.1967","article-title":"Biology of the adenomatous polyposis coli tumor suppressor","volume":"18","author":"Goss","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.humimm.2026.111703_b0190","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/1097-0142(19920901)70:3+<1236::AID-CNCR2820701508>3.0.CO;2-4","article-title":"The national polyp study design, methods, and characteristics of patients with newly diagnosed polyps","volume":"70","author":"Winawer","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.humimm.2026.111703_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121008","article-title":"Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses","volume":"309","author":"Adibfar","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.humimm.2026.111703_b0200","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1002\/1097-0142(19930615)71:12<3819::AID-CNCR2820711206>3.0.CO;2-L","article-title":"Variation in colorectal cancer incidence in the United States by subsite of origin","volume":"71","author":"Devesa","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.humimm.2026.111703_b0205","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/BF02237425","article-title":"Colorectal cancer before the age of 40: a case-control study","volume":"43","author":"Paraf","year":"2000","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.humimm.2026.111703_b0210","unstructured":"P. Helisz, N. Kaczmarczyk, B. Ca\u0142yniuk, Oty\u0142o\u015b\u0107 w kontek\u015bcie onkologii, in."},{"key":"10.1016\/j.humimm.2026.111703_b0215","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1067\/mge.2000.105082","article-title":"Colonic neoplasia in patients with nonspecific GI symptoms","volume":"51","author":"Lieberman","year":"2000","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.humimm.2026.111703_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108288","article-title":"Simultaneous blockade of TIGIT and HIF-1\u03b1 induces synergistic anti-tumor effect and decreases the growth and development of cancer cells","volume":"101","author":"Fathi","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2026.111703_b0225","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3748\/wjg.v17.i7.848","article-title":"Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: which is superior?","volume":"17","author":"Popek","year":"2011","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.humimm.2026.111703_b0230","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.biopha.2014.10.019","article-title":"Colon cancer: cancer stem cells markers, drug resistance and treatment","volume":"68","author":"Kozovska","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.humimm.2026.111703_b0235","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jnci\/dji204","article-title":"Detection in fecal DNA of colon cancer\u2013specific methylation of the nonexpressed vimentin gene","volume":"97","author":"Chen","year":"2005","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.humimm.2026.111703_b0240","unstructured":"Phase IB Study of Pembrolizumab (MK-3475) in Subjects With Select Advanced Solid Tumors, in, 2014."},{"key":"10.1016\/j.humimm.2026.111703_b0245","unstructured":"A Phase 2 Clinical Trial of Nivolumab, or Nivolumab Combinations in Recurrent and Metastatic Microsatellite Instability High (MSI-H) and Non-MSI-H Colon Cancer, in, 2013."},{"key":"10.1016\/j.humimm.2026.111703_b0250","unstructured":"A Phase II Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects With Previously Treated Locally Advanced Unresectable or Metastatic (Stage IV) Mismatched Repair Deficient or Microsatellite Instability-High Colorectal Carcinoma (KEYNOTE-164), in, 2015."},{"key":"10.1016\/j.humimm.2026.111703_b0255","unstructured":"A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177), in, 2015."},{"key":"10.1016\/j.humimm.2026.111703_b0260","unstructured":"Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer (Amended Protocol of: Nivolumab, Ipilimumab and COX2-inhibition in Early Stage Colon Cancer: an Unbiased Approach for Signals of Sensitivity: The NICHE TRIAL), in: S. Bristol-Myers (Ed.), 2016."},{"key":"10.1016\/j.humimm.2026.111703_b0265","unstructured":"Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement Versus Surgery Alone for Left-Sided Obstructive Colonic Cancer, in, 2022."},{"key":"10.1016\/j.humimm.2026.111703_b0270","unstructured":"Single Arm Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Locally Advanced Colon Cancers, in, 2023."},{"key":"10.1016\/j.humimm.2026.111703_b0275","unstructured":"Multi-omics Study of Intestinal Microecology in Patients with Colorectal Cancer Related to Immunotherapy, in, 2024."},{"key":"10.1016\/j.humimm.2026.111703_b0280","year":"2024","journal-title":"Phase \u2161 Clinical Trial, in"},{"key":"10.1016\/j.humimm.2026.111703_b0285","unstructured":"A Phase 2, Open Label, Randomized Study of Neoadjuvant Dostarlimab Plus CAPEOX Versus CAPEOX in Participants With Previously Untreated T4N0 or Stage III MMRp\/ MSS Colon Cancer, in, 2024."},{"key":"10.1016\/j.humimm.2026.111703_b0290","unstructured":"Phase II Open-label Trial of Neoadjuvant Immunotherapy (Atezolizumab) in Combination With CAPOX for Resectable Non-metastatic Proficient Mismatch Repair (pMMR) Colon CancER: NICER Study, in: I. Genentech (Ed.), 2023."},{"key":"10.1016\/j.humimm.2026.111703_b0295","unstructured":"A Phase II Study of Immunotherapies (Tiragolumab and Atezolizumab) in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC), in, 2024."},{"key":"10.1016\/j.humimm.2026.111703_b0300","unstructured":"Efficacy and Safety of Autologous Tumor-Infiltrating Lymphocytes (TIL) Therapy Combined With Immunotherapy in Patients With Advanced or Metastatic Refractory Colon and Rectal Cancer (Colorectum), in, 2024."},{"key":"10.1016\/j.humimm.2026.111703_b0305","unstructured":"Postoperative Chemotherapy With\/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence: A Randomized Controlled Phase II Trial, in, 2023."},{"key":"10.1016\/j.humimm.2026.111703_b0310","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17\u2013producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0315","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.165.11.6107","article-title":"Microbial lipopeptides induce the production of IL-17 in Th cells","volume":"165","author":"Infante-Duarte","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0320","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/iub.2660","article-title":"The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia","volume":"75","author":"Abolhasani","year":"2023","journal-title":"IUBMB Life"},{"key":"10.1016\/j.humimm.2026.111703_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119369","article-title":"Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression","volume":"275","author":"Joshi","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.humimm.2026.111703_b0330","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mi.2009.100","article-title":"Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa","volume":"2","author":"Khader","year":"2009","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0335","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0340","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0345","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12964-023-01213-1","article-title":"Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide","volume":"21","author":"Khodakarami","year":"2023","journal-title":"Cell Commun. Signaling"},{"key":"10.1016\/j.humimm.2026.111703_b0350","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.immuni.2009.09.014","article-title":"T helper 17 cells promote cytotoxic T cell activation in tumor immunity","volume":"31","author":"Martin-Orozco","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2026.111703_b0355","doi-asserted-by":"crossref","first-page":"11541","DOI":"10.1038\/ncomms11541","article-title":"Experimental priming of encephalitogenic Th1\/Th17 cells requires pertussis toxin-driven IL-1\u03b2 production by myeloid cells","volume":"7","author":"Ronchi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2026.111703_b0360","doi-asserted-by":"crossref","first-page":"27861","DOI":"10.1038\/s41598-025-97192-z","article-title":"Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs","volume":"15","author":"Al-Ameer","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2026.111703_b0365","article-title":"Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine\/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles","volume":"77","author":"Feizi","year":"2022","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.humimm.2026.111703_b0370","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12935-024-03393-3","article-title":"The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha","volume":"24","author":"Sadeghi","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.humimm.2026.111703_b0375","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1158\/0008-5472.CAN-14-0160","article-title":"Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak\/STAT3 signaling","volume":"74","author":"Lapeire","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2026.111703_b0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/his.12156","article-title":"Interleukin\u201017\u2010producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor","volume":"63","author":"Chen","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.humimm.2026.111703_b0385","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12935-023-02996-6","article-title":"Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art","volume":"23","author":"Hatami","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.humimm.2026.111703_b0390","article-title":"The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer","volume":"2013","author":"Alizadeh","year":"2013","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2026.111703_b0395","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/gtc.12039","article-title":"Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells","volume":"18","author":"Kurebayashi","year":"2013","journal-title":"Genes Cells"},{"key":"10.1016\/j.humimm.2026.111703_b0400","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0405","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00281-009-0187-y","article-title":"Development, regulation and functional capacities of Th17 cells","volume":"32","author":"Hirota","year":"2010","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.humimm.2026.111703_b0415","first-page":"357","article-title":"TGF-\u03b2 signaling in T cells is not essential for Th17 cell development in the mouse","volume":"26","author":"Schumann","year":"2012","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.humimm.2026.111703_b0420","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/eji.200838511","article-title":"IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo","volume":"38","author":"Sonderegger","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0425","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2026.111703_b0430","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0435","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2026.111703_b0440","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.111703_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119132","article-title":"The role of regulatory T cells in the pathogenesis and treatment of prostate cancer","volume":"284","author":"Karpisheh","year":"2021","journal-title":"Life Sci."},{"issue":"2007","key":"10.1016\/j.humimm.2026.111703_b0450","first-page":"1341","article-title":"T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity, Journal of immunology (Baltimore","volume":"178","author":"Gocke","year":"1950","journal-title":"MD"},{"key":"10.1016\/j.humimm.2026.111703_b0455","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0460","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/iub.2461","article-title":"T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer","volume":"73","author":"Fathi","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.humimm.2026.111703_b0465","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0470","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20061738","article-title":"IL-25 regulates Th17 function in autoimmune inflammation","volume":"204","author":"Kleinschek","year":"2007","journal-title":"J. Exp. Med."},{"issue":"2007","key":"10.1016\/j.humimm.2026.111703_b0475","first-page":"1423","article-title":"Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression, Journal of immunology (Baltimore","volume":"179","author":"Kryczek","year":"1950","journal-title":"MD"},{"key":"10.1016\/j.humimm.2026.111703_b0480","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1084\/jem.20070994","article-title":"Ets-1 is a negative regulator of Th17 differentiation","volume":"204","author":"Moisan","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0485","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2026.111703_b0490","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2013.10.004","article-title":"Th9 cells, new players in adaptive immunity","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0495","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173235","article-title":"Silencing of HIF-1\u03b1\/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression","volume":"882","author":"Hajizadeh","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.humimm.2026.111703_b0505","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061650","article-title":"Role and potential of different T Helper Cell Subsets in Adoptive Cell Therapy","volume":"15","author":"Andreu-Sanz","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2026.111703_b0510","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/j.1349-7006.2010.01624.x","article-title":"Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer","volume":"101","author":"Maruyama","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.humimm.2026.111703_b0515","first-page":"6770","article-title":"Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage, Clinical cancer research : an official journal of the American Association for","volume":"14","author":"Koyama","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2026.111703_b0520","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ccell.2018.05.004","article-title":"Th9 Cells Represent a Unique Subset of CD4(+) T Cells Endowed with the Ability to Eradicate Advanced Tumors","volume":"33","author":"Lu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humimm.2026.111703_b0525","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201207-1307OC","article-title":"Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion","volume":"186","author":"Ye","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.humimm.2026.111703_b0530","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.5001\/omj.2020.08","article-title":"Effects of Hyperbaric Oxygen on T helper 17\/regulatory T Polarization in Antigen and Collagen-induced Arthritis: Hypoxia-inducible Factor-1\u03b1 as a Target","volume":"35","author":"Harnanik","year":"2020","journal-title":"Oman Med. J."},{"key":"10.1016\/j.humimm.2026.111703_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103203","article-title":"Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies","volume":"107","author":"Vakili-Samiani","year":"2021","journal-title":"DNA Repair"},{"key":"10.1016\/j.humimm.2026.111703_b0540","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0545","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ni.2925","article-title":"The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells","volume":"15","author":"V\u00e9gran","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0550","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.intimp.2017.08.031","article-title":"Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer","volume":"52","author":"You","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2026.111703_b0555","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-17-0479","article-title":"Exosomes Released from Tumor-Associated Macrophages transfer miRNAs that Induce a Treg\/Th17 Cell Imbalance in Epithelial Ovarian Cancer","volume":"6","author":"Zhou","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.humimm.2026.111703_b0560","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12026-021-09211-6","article-title":"Recent advances in the role of Th17\/Treg cells in tumor immunity and tumor therapy","volume":"69","author":"Qianmei","year":"2021","journal-title":"Immunol. Res."},{"key":"10.1016\/j.humimm.2026.111703_b0565","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0570","article-title":"Different T cell related immunological profiles in COVID-19 patients compared to healthy controls","volume":"97","author":"A. Mahmoud Salehi Khesht, V. Karpisheh, B. Qubais Saeed, A. Olegovna Zekiy, L.M. Yapanto, M. Nabi Afjadi, M. Aksoun, M. Nasr Esfahani, F. Aghakhani, M. Movahed, N. Joshi, K. Abbaszadeh-Goudarzi, S. Hallaj, M. Ahmadi, S. Dolati, A. Mahmoodpoor, V. Hashemi, F. Jadidi-Niaragh,","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2026.111703_b0575","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12935-022-02660-5","article-title":"The molecular biology and therapeutic potential of Nrf2 in leukemia","volume":"22","author":"Khodakarami","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.humimm.2026.111703_b0580","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00281-016-0599-4","article-title":"T(H)9 cells in anti-tumor immunity","volume":"39","author":"Rivera Vargas","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.humimm.2026.111703_b0585","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","article-title":"Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells","volume":"163","author":"Atarashi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2026.111703_b0590","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41590-024-01909-7","article-title":"An intestinal T(H)17 cell-derived subset can initiate cancer","volume":"25","author":"Fesneau","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0595","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm.2015","article-title":"A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses","volume":"15","author":"Wu","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0600","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/2159-8290.CD-15-0447","article-title":"Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis","volume":"5","author":"Geis","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.humimm.2026.111703_b0605","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/mi.2016.53","article-title":"The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis","volume":"10","author":"Thiele Orberg","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0610","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s42255-022-00558-0","article-title":"The gut microbial metabolite formate exacerbates colorectal cancer progression","volume":"4","author":"Ternes","year":"2022","journal-title":"Nature Metabolism"},{"key":"10.1016\/j.humimm.2026.111703_b0615","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.963638","article-title":"Chinese herbal medicine anticancer cocktail soup activates immune cells to kill colon cancer cells by regulating the gut microbiota-Th17 axis","volume":"13","author":"Nie","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.humimm.2026.111703_b0620","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1038\/s41467-023-40622-1","article-title":"ROR\u03b3t-Raftlin1 complex regulates the pathogenicity of Th17 cells and colonic inflammation","volume":"14","author":"Singh","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2026.111703_b0625","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/ni.3488","article-title":"Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-\u03b3t ubiquitination","volume":"17","author":"Kathania","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0630","doi-asserted-by":"crossref","first-page":"14963","DOI":"10.1074\/jbc.M111.218867","article-title":"Marked induction of c-Maf protein during Th17 cell differentiation and its implication in memory Th cell development","volume":"286","author":"Sato","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.111703_b0635","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007607","article-title":"Gounari, \u03b2-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells","volume":"6","author":"Keerthivasan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0640","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90547","article-title":"\u03b2-catenin and PI3K\u03b4 inhibition expands precursor Th17 cells with heightened stemness and antitumor activity","volume":"2","author":"Majchrzak","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.humimm.2026.111703_b0645","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2013.08.049","article-title":"Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease","volume":"145","author":"Ogino","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humimm.2026.111703_b0650","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111703_b0655","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2017.02.006","article-title":"Inflammatory cytokines IL-17 and TNF-\u03b1 up-regulate PD-L1 expression in human prostate and colon cancer cells","volume":"184","author":"Wang","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.humimm.2026.111703_b0660","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1476-4598-10-150","article-title":"IL-17 induces AKT-dependent IL-6\/JAK2\/STAT3 activation and tumor progression in hepatocellular carcinoma","volume":"10","author":"Gu","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.humimm.2026.111703_b0665","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1089\/dna.2017.3814","article-title":"CD19(lo)CD27(hi) Plasmablasts Suppress Harmful Th17 Inflammation through Interleukin 10 Pathway in Colorectal Cancer","volume":"36","author":"Mao","year":"2017","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.humimm.2026.111703_b0670","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijms26010006","article-title":"Neutrophil and Colorectal Cancer","volume":"26","author":"Masui","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111703_b0675","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1479505","article-title":"The role of interleukin-17 in inflammation-related cancers","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0680","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.32604\/or.2025.060063","article-title":"Plasticity of myeloid-derived suppressor cells in cancer and cancer therapy","volume":"33","author":"Lv","year":"2025","journal-title":"Oncol. Res."},{"key":"10.1016\/j.humimm.2026.111703_b0685","doi-asserted-by":"crossref","first-page":"497","DOI":"10.37349\/etat.2022.00097","article-title":"Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets","volume":"3","author":"Al-Mterin","year":"2022","journal-title":"Exploration of Targeted Anti-Tumor Therapy"},{"key":"10.1016\/j.humimm.2026.111703_b0690","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184036","article-title":"Cxcr3 promotes protection from colorectal cancer liver metastasis by driving NK cell infiltration and plasticity","volume":"135","author":"Russo","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2026.111703_b0695","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3389\/fimmu.2019.00771","article-title":"Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression","volume":"10","author":"Bruno","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0700","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"\u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2026.111703_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101072","article-title":"Systematic analysis of human colorectal cancer scRNA-seq revealed limited pro-tumoral IL-17 production potential in gamma delta T cells","volume":"58","author":"Ran","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.humimm.2026.111703_b0710","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1038\/onc.2014.286","article-title":"Th17-type cytokines, IL-6 and TNF-\u03b1 synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth","volume":"34","author":"De Simone","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.humimm.2026.111703_b0715","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1038\/s41467-020-16363-w","article-title":"TGF-\u03b2 signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer","volume":"11","author":"Perez","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2026.111703_b0720","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/gutjnl-2014-308227","article-title":"Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer","volume":"65","author":"Punkenburg","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.humimm.2026.111703_b0725","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/jcp.24796","article-title":"Interleukin-17 induces CC chemokine receptor 6 expression and cell migration in colorectal cancer cells","volume":"230","author":"Chin","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"2019","key":"10.1016\/j.humimm.2026.111703_b0730","first-page":"2532","article-title":"IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA damage, and Upregulation of dual Oxidase 2 in Human Colon and Pancreatic Cancer Cells, Journal of immunology (Baltimore","volume":"203","author":"Wu","year":"1950","journal-title":"MD"},{"key":"10.1016\/j.humimm.2026.111703_b0735","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fimmu.2017.00044","article-title":"Defective IL-23\/IL-17 Axis Protects p47phox-\/- mice from Colon Cancer","volume":"8","author":"Richter","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0740","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41385-018-0018-3","article-title":"Colonic epithelial mTORC1 promotes ulcerative colitis through COX-2-mediated Th17 responses","volume":"11","author":"Lin","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0745","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/carcin\/bgu027","article-title":"Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells","volume":"35","author":"Rizzo","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humimm.2026.111703_b0750","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads3530","article-title":"T(H)17 cells regulate chemokine expression in epithelial cells through C\/EBP\u03b2 and dictate host sensitivity to colitis and cancer immunity","volume":"11","author":"Xing","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.humimm.2026.111703_b0755","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12967-023-04187-3","article-title":"IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8\u2009+\u2009T-cell tumour infiltration","volume":"21","author":"Feng","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0760","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jss.2016.09.038","article-title":"Local and systemic Th17 immune response associated with advanced stage colon cancer","volume":"208","author":"Sharp","year":"2017","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.humimm.2026.111703_b0765","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.biopha.2018.04.147","article-title":"Analysis of Th22, Th17 and CD4(+)cells co-producing IL-17\/IL-22 at different stages of human colon cancer","volume":"103","author":"Doulabi","year":"2018","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.humimm.2026.111703_b0770","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3748\/wjg.v26.i16.1912","article-title":"Interleukin-6 compared to the other Th17\/Treg related cytokines in inflammatory bowel disease and colorectal cancer","volume":"26","author":"Velikova","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.humimm.2026.111703_b0775","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1245\/s10434-015-4923-3","article-title":"A High ROR\u03b3T\/CD3 Ratio is a strong Prognostic factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes","volume":"23","author":"Yoshida","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.humimm.2026.111703_b0780","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/intimm\/dxs089","article-title":"Interplay between T(h)1 and T(h)17 effector T-cell pathways in the pathogenesis of spontaneous colitis and colon cancer in the G\u03b1i2-deficient mouse","volume":"25","author":"G\u00f6tlind","year":"2013","journal-title":"Int. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0785","article-title":"Cortex periplocae modulates the gut microbiota to restrict colitis and colitis-associated colorectal cancer via suppression of pathogenic Th17 cells","volume":"153","author":"Lin","year":"2022","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.humimm.2026.111703_b0790","article-title":"Ginseng berry concentrate prevents colon cancer via cell cycle, apoptosis regulation, and inflammation-linked Th17 cell differentiation","volume":"72","author":"Wang","year":"2021","journal-title":"Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society"},{"key":"10.1016\/j.humimm.2026.111703_b0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118854","article-title":"Saffron improves the efficacy of immunotherapy for colorectal cancer through the IL-17 signaling pathway","volume":"337","author":"Feng","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.humimm.2026.111703_b0800","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3892\/ol.2016.5329","article-title":"Effect of IL-17 in the development of colon cancer in mice","volume":"12","author":"Yang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.humimm.2026.111703_b0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115138","article-title":"Madecassic acid alleviates colitis-associated colorectal cancer by blocking the recruitment of myeloid-derived suppressor cells via the inhibition of IL-17 expression in \u03b3\u03b4T17 cells","volume":"202","author":"Yun","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.humimm.2026.111703_b0810","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1142\/S0192415X19500095","article-title":"Total Glycosides of Peony Protects against Inflammatory Bowel Disease by Regulating IL-23\/IL-17 Axis and Th17\/Treg Balance","volume":"47","author":"Li","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0815","first-page":"167","volume":"47","author":"Guo","year":"2022","journal-title":"China Journal of Chinese Materia Medica"},{"key":"10.1016\/j.humimm.2026.111703_b0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107683","article-title":"Juglone regulates gut microbiota and Th17\/Treg balance in DSS-induced ulcerative colitis","volume":"97","author":"Hua","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2026.111703_b0825","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X241313097","article-title":"Yiqi Jianpi Kangai Decoction Enhances the Chemotherapy effect by Inducing Apoptosis and Regulating Treg and Th17 Cells in Colorectal Cancer mice Model with Spleen Qi Deficiency","volume":"30","author":"Wang","year":"2025","journal-title":"Journal of Evidence-Based Integrative Medicine"},{"key":"10.1016\/j.humimm.2026.111703_b0830","article-title":"mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1\/TH17\/Treg Profile","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2026.111703_b0835","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/917149","article-title":"Antagonizing arachidonic acid-derived eicosanoids reduces inflammatory Th17 and Th1 cell-mediated inflammation and colitis severity","volume":"2014","author":"Monk","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.humimm.2026.111703_b0840","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001895","article-title":"Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer","volume":"9","author":"Liu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.humimm.2026.111703_b0845","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.humimm.2026.111703_b0850","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/cimb44050127","article-title":"The treatment with interleukin 17 inhibitors and immune-mediated inflammatory diseases","volume":"44","author":"\u021aiburc\u0103","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.humimm.2026.111703_b0855","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1136\/annrheumdis-2020-218719","article-title":"Paradoxical gastrointestinal effects of interleukin-17 blockers","volume":"82","author":"Mehta","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2026.111703_b0860","article-title":"Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer, Biochimica et Biophysica Acta (BBA)-Reviews on","volume":"1877","author":"Li","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.humimm.2026.111703_b0865","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2026.111703_b0870","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/imm.13397","article-title":"Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment","volume":"164","author":"Yang","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2026.111703_b0875","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2026.111703_b0880","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tim.2020.01.001","article-title":"Microbiome in Colorectal Cancer: how to get from Meta-omics to Mechanism?","volume":"28","author":"Ternes","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.humimm.2026.111703_b0885","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0890","first-page":"602","volume":"371","author":"Baruch","year":"2021","journal-title":"Fecal Microbiota Transplant Promotes Response in Immunotherapy-Refractory Melanoma Patients"},{"key":"10.1016\/j.humimm.2026.111703_b0895","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0900","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41582-020-0373-z","article-title":"CRISPR-based functional genomics for neurological disease","volume":"16","author":"Kampmann","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.humimm.2026.111703_b0905","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri.2017.76","article-title":"Single-cell RNA sequencing to explore immune cell heterogeneity","volume":"18","author":"Papalexi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2026.111703_b0910","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/gutjnl-2015-310016","article-title":"Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer","volume":"66","author":"Amicarella","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.humimm.2026.111703_b0915","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.humimm.2026.111703_b0920","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.humimm.2026.111703_b0925","article-title":"Clonal Evolution and Heterogeneity of Osimertinib acquired Resistance Mechanisms in EGFR Mutant Lung Cancer","volume":"1","author":"Roper","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.humimm.2026.111703_b0930","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2026.111703_b0935","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.7150\/jca.50509","article-title":"CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety","volume":"12","author":"Li","year":"2021","journal-title":"J. Cancer"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:27:38Z","timestamp":1781857658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":187,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0198885926000492"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111703","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111703"}}